Interestingly, recent studies showed ID2 functioned as a negative regulator of leukemia stem cell potential in MLL-rearranged AML, and ID2 overexpression suppressed MLL-rearranged and t(8;21) AML [17, 18]. The gene discussed is KMT2A; the disease is leukemia.